Evidence map›Paper›PMID 37764738›Full record

Trial reportNutrients2023

Effectiveness of the Telemedical Lifestyle Intervention Program TeLIPro for Improvement of HbA

Kerstin Kempf, Clara Dubois, Matthias Arnold, Volker Amelung, Nora Leppert, Sibel Altin, Markus Vomhof, Andrea Icks, Stephan Martin

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Nutrients, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Kerstin KempfWest-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany.ORCID 0000-0003-4285-3127
Clara Duboisinav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.
Matthias Arnoldinav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.
Volker Amelunginav-Private Institute for Applied Health Services Research GmbH, 10117 Berlin, Germany.
Nora LeppertGerman Institute for Telemedicine and Healthcare (DITG) GmbH, 40591 Düsseldorf, Germany.
Sibel AltinGeneral Health Insurance Scheme (AOK Rheinland/Hamburg-Die Gesundheitskasse), 40213 Düsseldorf, Germany.
Markus VomhofInstitute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
Andrea IcksInstitute for Health Services Research and Health Economics, German Diabetes Center, Leibniz Center for Diabetes Research at the Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany.
Stephan MartinWest-German Centre of Diabetes and Health, Düsseldorf Catholic Hospital Group, 40591 Düsseldorf, Germany.

Funding

Innovation Funds of the German Federal Ministry of Health 01NVF17033
6 · The paper itself

Abstract

The effectiveness of the multimodal Telemedical Lifestyle Intervention Program (TeLIPro) was proven in the advanced stages of type 2 diabetes mellitus (T2DM). Since its therapeutic potential focusing on telemedical coaching without using a formula diet is unknown, we evaluated improvements in HbA

Indexed as

Diabetes Mellitus, Type 2Behavior TherapyHealthy LifestyleHumansLife StyleQuality of Lifecardiovascular risk factorsHbA1chealth insurancelifestyle interventiontype 2 diabetesweight loss

Identifiers

PMID37764738
PMCPMC10534832

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.